Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 09-2025 | 07-2025 | 04-2025 | 01-2025 | 12-2024 | |
| Sales | 13,692 | 1,426 | 0 | 0 | 0 |
| Cost of Goods | 1,232 | 590 | N/A | N/A | N/A |
| Gross Profit | 12,460 | 836 | N/A | N/A | N/A |
| Operating Expenses | 58,742 | 60,435 | 0 | 42,940 | 0 |
| Operating Income | -46,050 | -59,009 | N/A | -42,940 | N/A |
| Interest Expense | 4,757 | 3,522 | 0 | 2,842 | 0 |
| Other Income | 3,482 | 4,592 | 0 | 1,520 | 0 |
| Pre-tax Income | -47,325 | -57,939 | 0 | -44,262 | 0 |
| Income Tax | 2,157 | 2,157 | N/A | 4,247 | N/A |
| Net Income Continuous | -49,482 | -60,096 | N/A | -48,509 | N/A |
| Net Income | $-49,482 | $-60,096 | $N/A | $-48,509 | $N/A |
| EPS Basic Total Ops | -0.92 | -1.12 | N/A | -0.92 | N/A |
| EPS Basic Continuous Ops | -0.92 | -1.12 | N/A | -0.92 | N/A |
| EPS Diluted Total Ops | -0.92 | -1.12 | N/A | -0.92 | N/A |
| EPS Diluted Continuous Ops | -0.92 | -1.12 | N/A | -0.92 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.92 | N/A | N/A | N/A | -0.92 |
| EBITDA(a) | $-46,050 | $-59,009 | $N/A | $-42,249 | $N/A |